NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma
Turkish Journal of Medical Sciences · 23.08.2024 · 54 (4) · 804-810
DOI: 10.55730/1300-0144.5852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 23.08.2024. Verfasst von Osman Türkmen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University, Ankara, …. Hauptthemen laut MEDLINE: Leiomyosarcoma, Uterine Neoplasms, Nicotinamide N-Methyltransferase. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Aim: Uterine leiomyosarcomas (uLMS) are extremely rare high-grade tumors with a poor prognosis. Their etiopathogenesis remains largely unknown. The uterus is the most frequent site for LMS. uLMS and uterine leiomyoma (uLM) must frequently be differentiated in patients with a uterine mass. Nicotinamide N-methyltransferase (NNMT), a cytoplasmic protein, is involved in the progression and spread of a variety of cancer types. The expression of NNMT in a mesenchymal malignancy was not examined previously. This study represents the first investigation into NNMT expression in uLMS, uLM and benign uterine myometrium and correlates NNMT overexpression with worse prognosis in uLMS. Materials/Methods: The expression of NNMT was investigated by immunohistochemistry on formalin-fixed paraffin-embedded tissue of uLMS in 31 patients, uLM in 7 patients and benign myometria in 31 patients.Results: The expression of NNMT in uLMS was markedly higher than in uLM and normal myometrial tissue (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Turkiye.
- Department of Pathology, Ankara Bilkent City Hospital, Ankara, Turkiye.
- Department of Pathology, Faculty of Medicine, Selçuk University, Konya, Turkiye.
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara Turkiye.
ORCID-Profile: Osman Türkmen, Kamil Hakan Müftüoğlu, Nazmiye Dinçer, Zeliha Esin Çelik, Serra Akar Inan
Zitieren
APA
Türkmen, O., Müftüoğlu, K. H., Dinçer, N., Çelik, Z. E., & Akar Inan, S. (2024). NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma. Turkish Journal of Medical Sciences, 54(4), 804-810. https://doi.org/10.55730/1300-0144.5852
Vancouver
Türkmen O, Müftüoğlu KH, Dinçer N, Çelik ZE, Akar Inan S. NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma. Turkish Journal of Medical Sciences. 2024;54(4):804-810. doi:10.55730/1300-0144.5852
BibTeX
@article{Trkmen2024,
author = {Türkmen, Osman and Müftüoğlu, Kamil Hakan and Dinçer, Nazmiye and Çelik, Zeliha Esin and Akar Inan, Serra},
title = {NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma},
journal = {Turkish Journal of Medical Sciences},
year = {2024},
volume = {54},
number = {4},
pages = {804--810},
doi = {10.55730/1300-0144.5852}
}
EUVIMED